Disease block
G70-G73 – Krankheiten im Bereich der neuromuskulären Synapse und des Muskels
- Chapter VI: Krankheiten des Nervensystems
9Decisions
14Patient groups
Added benefit by patient group
- Considerable1
- Non-quantifiable4
- Not proven9
Diseases in this disease block
- G70 Myasthenia gravis und sonstige neuromuskuläre Krankheiten 6 decisions
- G71 Primäre Myopathien 3 decisions
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2026-09-03UpliznaInebilizumabNot proven: 2 of 2 patient groups
- 2026-06-18ImaavyNipocalimabNot proven: 4 of 4 patient groups
- 2026-01-22DuvyzatGivinostatNon-quantifiable
- 2024-09-19VyvgartEfgartigimod alfaNot proven
- 2024-08-15RystiggoRozanolixizumabConsiderable: 1 of 2 patient groupsNon-quantifiable: 1 of 2 patient groups
- 2024-08-15ZilbrysqZilucoplanNot proven
- 2024-07-04AgamreeVamorolonNon-quantifiable
- 2023-04-20UltomirisRavulizumabNot proven
- 2019-08-01NamusclaMexiletinNon-quantifiable
Data status: 2026-10-29